Osteoarthritis trial part two: The use of 4CYTE Forte in dogs

spanish mastiff dogs lying on the ground

Is your dog possibly suffering from arthritis? Our University of Melbourne researchers are looking for dogs with symptoms of arthritis to participate in our new study.

About the trial

In our last clinical trial, we assessed the effectiveness of a new oral gel formulation of Epiitalis, a plant extract which is the principle active of a product called 4CYTE. The results showed that more than 50 per cent of the treated dogs improved after 28 days of treatment with Epiitalis alone. In this new study, we want to assess its effect when combined with other treatments.

What is the benefit to you and your pet?

  • Eligible dogs will receive a free health check as well as a lameness assessment using a pressure mat that analyses their gait. This will measure the strength of your pet’s steps as well as level of lameness or discomfort.
  • At the end of the trial, a rehabilitation program can be designed for you through U-Vet Pain Clinic with advice on what to do next to help your pet.
  • Free Epiitalis product for an additional month.

What will you need to do?

During the one month trial, you will need to take your pet to the U-Vet Hospital on two occasions (for the initial consultation and then at the end of the 28 day trial). You will also need to give the oral gel formulation to your pet once a day, for 28 days.

Eligibility

Dogs need to be over six months of age, showing signs of arthritis and able to visit U-Vet Animal Hospital in Werribee twice.

* Dogs that participated in the initial osteoarthritis clinical trial are eligible for this secondary study.

Enquiries

To find out more about the trial please call (03) 97312000 (Dr Richard Munn or Dr Thierry Beths) or email uvet-anaesthesia@unimelb.edu.au.

Search U-Vet Werribee Animal Hospital

Home | About U-Vet | Services for your pet | Equine Centre | Referring Vets | News | Contact Us

Subscribe to our newsletter | Donate to U-Vet | U-Vet Facebook | Equine Centre Facebook